The outcomes of considering goals of care in medication reviews for older adults: a systematic review

References

• World Health Organization. Global health and ageing 2011 [cited 2020 Feb 7]. Available from: https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf
   Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17(1):230. doi: 10.1186/s12877-017-0621-2
   PubMedGoogle Scholar
• Falster MO, Charrier R, Pearson S-A, et al. Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol. 2021;87(3):1264–1274. doi: 10.1111/bcp.14504
   PubMed Web of Science ®Google Scholar
• Fabbri E, Zoli M, Gonzalez-Freire M, et al. Aging and multimorbidity: new tasks, Priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015 Aug 1;16(8):640–647. doi: 10.1016/j.jamda.2015.03.013
   PubMed Web of Science ®Google Scholar
• Page AT, Falster MO, Litchfield M, et al. Polypharmacy among older Australians, 2006–2017: a population-based study. Med j Aust. 2019;211(2):71–75. doi: 10.5694/mja2.50244
   PubMed Web of Science ®Google Scholar
• Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in Community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–2272. doi: 10.1111/jgs.13153
   PubMed Web of Science ®Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015 May;175(5):827–834. doi: 10.1001/jamainternmed.2015.0324
   PubMed Web of Science ®Google Scholar
• Wastesson JW, Morin L, Tan ECK, et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018 Dec;17(12):1185–1196. doi: 10.1080/14740338.2018.1546841
   PubMed Web of Science ®Google Scholar
• Col N, Fanale JE, Kronholm P. The Role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Internal Med. 1990;150(4):841–845. doi: 10.1001/archinte.1990.00390160093019
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Naik AD, Dodson JA. Moving from disease-centered to patient goals-directed care for patients with Multiple chronic conditions: patient value-Based care. JAMA Cardiol. 2016 Apr 1;1(1):9–10. doi: 10.1001/jamacardio.2015.0248
   PubMed Web of Science ®Google Scholar
• Reuben DB, Tinetti ME. Goal-oriented patient care–an alternative health outcomes paradigm. N Engl J Med. 2012 Mar 1;366(9):777–779. doi: 10.1056/NEJMp1113631
   PubMed Web of Science ®Google Scholar
• Skou ST, Mair FS, Fortin M, et al. Multimorbidity. Nat Rev Dis Primers. 2022 Jul 14;8(1):48. doi: 10.1038/s41572-022-00376-4
   PubMedGoogle Scholar
• Liu Q, Schwartz JB, Slattum PW, et al. Roadmap to 2030 for Drug Evaluation in Older Adults. Clin Pharmacol Ther. 2022 Aug;112(2):210–223. doi: 10.1002/cpt.2452
   PubMed Web of Science ®Google Scholar
• Australian Commission on Safety and Quality in Health Care. Shared decision making. [2023 May 6] Available from: https://www.safetyandquality.gov.au/our-work/partnering-consumers/shared-decision-making
   Google Scholar
• Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–60. doi: 10.3399/bjgp16X685669
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Sawan MJ. Discussion of patients’ goals for pharmaceutical care is central to managing polypharmacy. J Pharm Pract Res. 2018;48(5):402–404. doi: 10.1002/jppr.1499
   Google Scholar
• Kaldjian LC, Curtis AE, Shinkunas LA, et al. Review article: goals of care toward the End of life: a structured literature review. Am J Hospice Palliative Med®. 2009;25(6):501–511. doi: 10.1177/1049909108328256
   Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch Ellett L, et al. Rationalisation of polypharmacy in practice: a survey of physicians and pharmacists. J Pharm Pract Res. 2019;50(3):233–241.
   Google Scholar
• Barker TH, Stone JC, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023 Mar 1;21(3):494–506. doi: 10.11124/JBIES-22-00430
   PubMedGoogle Scholar
• Tufanaru C, Munn Z, Aromataris E, et al. Chapter 3: Systematic reviews of effectiveness. JBI Manual For Evidence Synthesis. 2020. p. 71–133. doi: 10.46658/JBIMES-20-01
   Google Scholar
• Freytag J, Dindo L, Catic A, et al. Feasibility of clinicians aligning health care with patient Priorities in geriatrics ambulatory care. J Am Geriatr Soc. 2020 Sep;68(9):2112–2116. doi: 10.1111/jgs.16662
   PubMed Web of Science ®Google Scholar
• O’Donnell L K, Gnjidic D, Sawan M, et al. Impact of the goal-directed medication review Electronic decision Support System on drug Burden Index: a cluster-randomised clinical trial in primary care. Br J Clin Pharmacol. 2021 Mar;87(3):1499–1511. doi: 10.1111/bcp.14557
   PubMed Web of Science ®Google Scholar
• van Moerbeke A, Magdelijns F, Cleutjens F, et al. Development and evaluation of a clinic for elderly patients with rheumatoid arthritis and multimorbidity: a Pilot study. ACR Open Rheumatol. 2021 Jan;3(1):34–40. doi: 10.1002/acr2.11213
   PubMedGoogle Scholar
• Verdoorn S, Blom J, Vogelzang T, et al. The use of goal attainment scaling during clinical medication review in older persons with polypharmacy. Res Social Administrative Pharm. 2018;15(10):1259–1265. doi: 10.1016/j.sapharm.2018.11.002
   PubMed Web of Science ®Google Scholar
• Verdoorn S, Kwint HF, Blom JW, et al. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: a randomised controlled trial (DREAMeR-study). PLOS Med. 2019 May;16(5):e1002798. doi: 10.1371/journal.pmed.1002798
   PubMed Web of Science ®Google Scholar
• Afshar K, van Baal K, Wiese B, et al. Structured implementation of the supportive and palliative care indicators tool in general practice - a prospective interventional study with follow-up. BMC Palliat Care. 2022;21(1):214. doi: 10.1186/s12904-022-01107-y
   PubMed Web of Science ®Google Scholar
• Bruce ML, Raue PJ, Reilly CF, et al. Clinical effectiveness of integrating depression care management into medicare home health: the depression CAREPATH randomized trial. JAMA Intern Med. 2015;175(1):55–64. doi: 10.1001/jamainternmed.2014.5835
   PubMed Web of Science ®Google Scholar
• Bruce ML, Lohman MC, Greenberg RL, et al. Integrating depression care management into Medicare home health reduces risk of 30- and 60-day hospitalization: the depression care for patients at home cluster-randomized trial. J Am Geriatr Soc. 2016;64(11):2196–2203. doi: 10.1111/jgs.14440
   PubMed Web of Science ®Google Scholar
• Deters MA, Obarcanin E, Schwender H, et al. EMDIA Case series—effective medication therapy management (MTM) for diabetes type 2 patients—A proof of concept study. Pharmacy (Basel). 2021;9(3):137. doi: 10.3390/pharmacy9030137
   PubMedGoogle Scholar
• Doucette WR, Witry MJ, Farris KB, et al. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43(5):882–889. doi: 10.1345/aph.1L605
   PubMed Web of Science ®Google Scholar
• Garcia BH, Giverhaug T, Høgli JU, et al. A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial. Pharm Pract (Granada). 2015;13(2):575. doi: 10.18549/PharmPract.2015.02.575
   PubMedGoogle Scholar
• Hikaka J, Hughes C, Jones R, et al. Feasibility of a pharmacist-facilitated medicines review intervention for community-dwelling māori older adults. Explor Res Clin Soc Pharm. 2021;2:100018. doi: 10.1016/j.rcsop.2021.100018
   PubMedGoogle Scholar
• Lai PS, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm. 2013;35(4):629–637. doi: 10.1007/s11096-013-9784-x
   PubMed Web of Science ®Google Scholar
• Molist-Brunet N, Sevilla-Sánchez D, Puigoriol-Juvanteny E, et al. Improving individualized prescription in patients with multimorbidity through medication review. BMC Geriatr. 2022;22(1):417. doi: 10.1186/s12877-022-03107-2
   PubMed Web of Science ®Google Scholar
• Twigg MJ, Wright D, Barton G, et al. The pharmacy care plan service: evaluation and estimate of cost-effectiveness. Res Social Adm Pharm. 2019;15(1):84–92. doi: 10.1016/j.sapharm.2018.03.062
   PubMed Web of Science ®Google Scholar
• Verdoorn S, van de Pol J, Hövels AM, et al. Cost-utility and cost-effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: economic evaluation of the DREAMeR study. Br J Clin Pharmacol. 2021;87(2):588–597. doi: 10.1111/bcp.14421
   PubMed Web of Science ®Google Scholar
• Vogelsmeier A, Popejoy L, Crecelius C, et al. APRN-Conducted medication reviews for long-stay nursing home residents. J Am Med Dir Assoc. 2018;19(1):83–85. doi: 10.1016/j.jamda.2017.10.012
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A Drug Burden Index to Define the Functional Burden of Medications in Older People. JAMA Intern Med. 2007;167(8):781–787. doi: 10.1001/archinte.167.8.781
   Google Scholar
• Reeve E, Low LF, Shakib S, et al. Development and validation of the revised patients’ attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016 Dec;33(12):913–928. doi: 10.1007/s40266-016-0410-1
   PubMed Web of Science ®Google Scholar
• Muth C, Blom JW, Smith SM, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med. 2019 Mar;285(3):272–288. doi: 10.1111/joim.12842
   PubMed Web of Science ®Google Scholar
• Peters M, Crocker H, Dummett S, et al. Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures. Health Qual Life Outcomes. 2014 Aug 12;12(1):123. doi: 10.1186/s12955-014-0123-2
   PubMedGoogle Scholar
• Dunlay SM, Strand JJ. How to discuss goals of care with patients. Trends Cardiovasc Med. 2016 Jan;26(1):36–43. doi: 10.1016/j.tcm.2015.03.018
   PubMed Web of Science ®Google Scholar
• Caughey GE, Tait K, Vitry AI, et al. Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity. Patient Preference Adherence. 2017 Jan 21;11:131–140.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Shared decision making 2023 may 06. Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making
   Google Scholar
• World Health Organization. Patients for patient safety 2023 May 06. Available from: https://www.who.int/initiatives/patients-for-patient-safety
   Google Scholar
• World Health Organization. Patient Engagement. 2016 [cited 2023 May 6]. Available from: https://apps.who.int/iris/handle/10665/252269
   Google Scholar
• Veronese N, Custodero C, Demurtas J, et al. Comprehensive geriatric assessment in older people: an umbrella review of health outcomes. Age Ageing. 2022;51(5). doi: 10.1093/ageing/afac104
   Web of Science ®Google Scholar